BioSpace News Archive

Career Advice

How to Position Yourself for a Career Change

Regardless of if your motivation is to increase your salary or find a job that is more interesting to you, preparing for a career change can take a lot of time and energy.

November 5, 2019
·
3 min read
·
Porschia Parker
8 Drugs Approved in the Past Year to Treat Conditions You’ve Probably Never Heard Of

The eight new drugs listed below probably won’t make any television commercials, but they will make a world of difference to those who suffer from these rare diseases and disorders.

November 5, 2019
·
5 min read
·
Stephanie DeClue
Business

Santhera Appoints New Chief Executive Officer

Santhera Pharmaceuticals announces a strategic change to its management team with the appointment of Dario Eklund as CEO, effective December 1, 2019.

November 5, 2019
·
5 min read
Policy

New drug for mild and moderate Alzheimer’s approved in China

Shanghai Green Valley Pharmaceuticals announced that China’s National Medical Products Administration has approved Oligomannate as new drug for the treatment of mild to moderate Alzheimer’s disease.

November 5, 2019
·
1 min read
Business

Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector

Kayentis, a global provider of eCOA solutions for clinical trials, announces the opening of a subsidiary in Japan, the world’s third largest pharmaceutical market, where clinical developments have been expanding.

November 5, 2019
·
3 min read
Business

Nosopharm welcomes Jacques Biton and Frédéric Hammel to its supervisory board

Nosopharm, a company dedicated to the research and development of new anti-infective drugs, announces changes to its supervisory board: Jacques Biton has been appointed as chairman, taking over from Gilles Alberici, while Frédéric Hammel joins the board as a member, representing Elaia Partners.

November 5, 2019
·
3 min read
PharmaMar has presented Yondelis® data in ovarian cancer at ESGO

PharmaMar has presented data from the Phase IV NIMES-ROC clinical trial with its marine-derived anti-tumor compound, Yondelis®, at the European Congress of Oncological Gynecology, being held from 2-5 November in Athens, Greece..

November 5, 2019
·
3 min read
Business

GVK Bio continues to see growth tailwinds for 2020 thanks to a ‘crescendo of factors’

China-US trade challenges has led to de-risking by pharma companies

November 5, 2019
·
3 min read
Eveliqure’s effort to develop a Shigella-ETEC combination vaccine for travelers and children in resource poor countries is supported by the Wellcome Trust

Eveliqure Biotechnologies announces the grant of a Wellcome Trust Innovator Award that supports the early clinical development of its Shigella-ETEC combination vaccine with ~£500K and complements the previously secured ~€11 million funding from public sources for the vaccine’s development

November 5, 2019
·
2 min read
FDA

RedHill’s Talicia Becomes Only Rifabutin-Based Therapy Approved for H. Pylori

In clinical trials, Talicia demonstrated 90% efficacy in the eradication of H. pylori in studies and is the only rifabutin-based therapy on the market.

November 5, 2019
·
2 min read
·
Alex Keown